Thiazolidinediones increased risk for heart failure, myocardial infarction, and death in older patients with type 2 diabetes

被引：1
|
作者：
Padwal, Raj [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
来源：
ANNALS OF INTERNAL MEDICINE | 2008年 / 148卷 / 12期
关键词：
D O I：
10.7326/0003-4819-148-12-200806170-02013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Malnutrition a risk factor for myocardial infarction in patients with type-2 diabetes
    Laghari, Arshad Hussain
    Memon, Allah Nawaz
    Memon, Muhammad Saleh
    RAWAL MEDICAL JOURNAL, 2010, 35 (01): : 57 - 60
  • [42] Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS
    Nauck, Michael A.
    McGuire, Darren K.
    Pieper, Karen S.
    Lokhnygina, Yuliya
    Strandberg, Timo E.
    Riefflin, Axel
    Delibasi, Tuncay
    Peterson, Eric D.
    White, Harvey D.
    Scott, Russell
    Holman, Rury R.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (01)
  • [43] Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS
    Michael A. Nauck
    Darren K. McGuire
    Karen S. Pieper
    Yuliya Lokhnygina
    Timo E. Strandberg
    Axel Riefflin
    Tuncay Delibasi
    Eric D. Peterson
    Harvey D. White
    Russell Scott
    Rury R. Holman
    Cardiovascular Diabetology, 18
  • [44] Effect of Hyperketonemia on Myocardial Function in Patients With Heart Failure and Type 2 Diabetes
    Solis-Herrera, Carolina
    Qin, Yuejuan
    Honka, Henri
    Cersosimo, Eugenio
    Triplitt, Curtis
    Neppala, Sivaram
    Rajan, Jemena
    Acosta, Francisca M.
    Moody, Alexander J.
    Iozzo, Patricio
    Fox, Peter
    Clarke, Geoffrey
    Defronzo, Ralph A.
    DIABETES, 2025, 74 (01)
  • [45] Dapagliflozin in patients with myocardial infarction without diabetes or prior heart failure
    James, Stefan
    Storey, Robert F.
    Oldgren, Jonas
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (02) : 91 - 92
  • [46] Type 2 diabetes, thiazolidinediones, and cardiovascular risk
    Taylor, Clare
    Hobbs, F. D. Richard
    BRITISH JOURNAL OF GENERAL PRACTICE, 2009, 59 (564): : 520 - 524
  • [47] DoxorubicinCardiac death with myocardial infarction and heart failure: 2 case reports
    Reactions Weekly, 2022, 1913 (1) : 192 - 192
  • [48] Are myocardial bridges associated with increased risk of death or myocardial infarction?
    Al-Mallah, M.
    Kassem, K.
    Khawaja, O.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0A) : A71 - A71
  • [49] HEART FAILURE EVENTS AFTER TYPE 2 MYOCARDIAL INFARCTION
    McCarthy, Cian P.
    Murphy, Sean
    Rehman, Saad
    Jones-O'Connor, Maeve
    Olshan, David
    Cohen, Joshua
    Cui, Jinghan
    Singh, Avinainder
    Vaduganathan, Muthiah
    Januzzi, James
    Wasfy, Jason H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 125 - 125
  • [50] Increased Mortality Risk after Myocardial Infarction in Patients with Diabetes and Depression
    Bot, Mariska
    Pouwer, Frans
    Zuidersma, Marij
    Van Melle, Joost P.
    De Jonge, Peter
    DIABETES, 2011, 60 : A83 - A84
12345